Active Pharmaceutical Ingredient (API) intermediates and key starting materials (KSMs) are the essential chemical compounds that serve as the foundational building blocks in the multi-step synthesis of a final API. The quality, purity, and consistency of intermediates and KSMs directly impact the final medicine's safety, efficacy, and stability.
Our expertise in the development and manufacturing of these critical intermediates & KSMs ensures a robust and reliable path from raw materials to a high-quality, regulatory-compliant API.
Start a ProjectIdentifying and refining the most efficient, scalable, and cost-effective synthetic pathways for the target API.
Transitioning the manufacturing process from laboratory to clinical and then to commercial scales, ensuring reproducibility and consistency.
All production conducted in facilities adhering to strict ICH Q7 Good Manufacturing Practice (GMP) guidance to ensure uniform quality.
Rigorous quality control checks including mass spectrometry, NMR and HPLC to verify structure, purity, and consistency of each batch.
Leveraging advanced synthetic chemistry and process optimisation techniques to produce a wide range of drug intermediates.
Complete regulatory-grade documentation and characterisation meeting ICH guidelines for global pharmaceutical submissions.
The quality, purity, and consistency of intermediates directly impact the final medicine's safety, efficacy, and stability. We ensure excellence at every stage.